½ÃÀ庸°í¼­
»óǰÄÚµå
1449568

¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå : À¯Çüº°, Á¦Ç°º°, ¿ëµµº°, ÀûÀÀ Áúȯº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Global Electroretinogram Market, By Type, By Product, By Application, By Disease Indication, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀåÀº 2024³â¿¡´Â 4,870¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2031³â¿¡´Â 9,010¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2031³âÀÇ CAGRÀº 9.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¸®Æ÷Æ® ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁسâ 2023 2023/2024³â ½ÃÀå ±Ô¸ð 4,870¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031
¿¹Ãø ±â°£2023/2024-2030/2031 CAGR : 9.20% 2030/2031³âÀÇ ¿¹ÃøÄ¡ 9,010¸¸ ´Þ·¯
µµÇ¥ 1. ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Global Electroretinogram Market-IMG1

¸Á¸·Àüµµ´Â ¸Á¸·ÀÇ °Ç°­ »óÅÂ¿Í ±â´ÉÀ» Æò°¡Çϱâ À§ÇÑ Áø´Ü¿ë ÀÇ·á °Ë»çÀÔ´Ï´Ù. ¸Á¸·ÀÌ ºû Àڱؿ¡ ¾î¶»°Ô ¹ÝÀÀÇÏ´ÂÁö¸¦ ±â·ÏÇÏ¿© ¸Á¸·ÀÇ Àü±âÀû Ȱµ¿À» °´°üÀûÀ¸·Î ÃøÁ¤ÇÕ´Ï´Ù. °Ë»ç¿¡¼­´Â ȯÀÚÀÇ ¾È±¸ Ç¥¸é°ú µÎÇÇ¿¡ Àü±ØÀ» ¼³Ä¡ÇÕ´Ï´Ù. ÀÌÈÄ ±¤¿øÀ¸·Î ¸Á¸·À» ºñÃ߸鼭 Àü±âÀû ¹ÝÀÀÀ» ±â·ÏÇÕ´Ï´Ù. ¸Á¸·ÀüÀ§µµ ¶Ç´Â ¸Á¸·ÀüÀ§µµ(ERG)´Â ¸Á¸·ÀÇ Áý´ÜÀû Àü±âÀû ¹ÝÀÀÀ» ÃøÁ¤ÇÏ¿© ¸Á¸·»ö¼Òº¯¼ºÁõ°ú °°Àº Áúȯ°ú °ü·ÃµÈ ¸Á¸·ÀÇ ÀÌ»óÀ» °¨ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. Àü ¼¼°è¿¡¼­ ¸Á¸· ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾È°ú ÁúȯÀÇ Áø´Ü°ú °ü¸®¸¦ °³¼±Çϱâ À§ÇØ ERG¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°è ¸Á¸·ÀüÀ§µµ ½ÃÀåÀº ³ëÈ­·Î ÀÎÇÑ ¸Á¸· Áúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡, ´ç´¢º´¼º ¸Á¸·Áõ ¹ßº´·ü Áõ°¡, ¾È°ú ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ´ÙÃÊÁ¡ ¸Á¸·ÀüÀ§µµ¸¦ ÅëÇÕÇÑ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¸¹Àº ½ÅÈï ±¹°¡¿¡¼­´Â ¸Á¸·ÀüÀ§µµ ÀåºñÀÇ ³ôÀº ºñ¿ë°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·À¸·Î ÀÎÇØ °³¹ßÀÌ ¾ïÁ¦µÉ ¼ö ÀÖ½À´Ï´Ù. ½ÅÈï ±¹°¡µéÀº ±Þ¼ÓÇÑ °æÁ¦ ¹ßÀü°ú ÀÇ·á ÀÎÇÁ¶ó È®ÃæÀ¸·Î ½ÃÀå °³Ã´Àڵ鿡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, POC(Point-of-Care) °Ë»ç¸¦ À§ÇÑ ÈÞ´ë¿ë ±â±âÀÇ ¿¬±¸°³¹ß(R&D)¿¡ ÅõÀÚÇÏ´Â Á¦Á¶¾÷üµé¿¡°Ôµµ ±âȸ°¡ È®´ëµÉ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÃËÁø¿äÀÎÀº Ȳ¹Ýº¯¼º, ³ì³»Àå µî ³ëÈ­¿¡ µû¸¥ ¸Á¸· Áúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡ÀÔ´Ï´Ù. Àü ¼¼°è¿¡¼­ ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÁúȯÀÇ Áø´Ü ¹× ¸ð´ÏÅ͸µÀ» À§ÇÑ ERG¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº ´ç´¢º´ÀÇ ÇÕº´ÁõÀÎ ´ç´¢º´¼º ¸Á¸·ÁõÀÇ ¹ßº´·üÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Àü ¼¼°è¿¡¼­ ´ç´¢º´ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾È°ú °ü·Ã ÇÕº´ÁõÀÇ Á¶±â ¹ß°ß ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ERG ÀåºñÀÇ »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´« °ü¸®¿Í Á¤±âÀûÀÎ ¾È°ú °ËÁøÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. °øÁߺ¸°Ç ³ë·Â°ú ´« °Ç°­¿¡ ´ëÇÑ ±³À° Ä·ÆäÀÎÀº ´õ ¸¹Àº »ç¶÷µéÀÌ ERG °Ë»ç¸¦ Æ÷ÇÔÇÑ Á¾ÇÕÀûÀÎ ¾È°ú °ËÁøÀ» ¹Þµµ·Ï µ¶·ÁÇϰí ÀÖ½À´Ï´Ù. ´ÙÃÊÁ¡ ¸Á¸·Àü»êÈ­´ÜÃþÃÔ¿µ°ú °°Àº ±â¼ú ¹ßÀüÀ¸·Î ERG ÀåºñÀÇ Á¤È®µµ¿Í È¿À²¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ´Ù¾çÇÑ ¸Á¸· ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ ERGÀÇ ¿ëµµ¸¦ È®´ëÇÏ¿© ¾È°ú Àǻ翡°Ô ±ÍÁßÇÑ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î ¼¼°èº¸°Ç±â±¸(WHO)°¡ 2022³â 10¿ù¿¡ Á¦°øÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2020³â¿¡´Â 60¼¼ ÀÌ»ó ³ëÀÎÀÇ ¼ö°¡ 5¼¼ ¹Ì¸¸ ¾î¸°À̺¸´Ù ¸¹À» °ÍÀ̸ç, 2015-2050³â ¼¼°è Àα¸¿¡¼­ 60¼¼ ÀÌ»óÀÌ Â÷ÁöÇÏ´Â ºñÁßÀº 12%¿¡¼­ 22%·Î °ÅÀÇ µÎ ¹è·Î Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù. ÀÇ Àα¸ ºñÁßÀº 2020³â 100¸¸ ¸í¿¡¼­ 140¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ̸ç, 2050³â±îÁö Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸´Â µÎ ¹è(210¸¸ ¸í)·Î Áõ°¡ÇÒ °ÍÀ̸ç, 80¼¼ ÀÌ»ó ³ëÀÎÀÇ ¼ö´Â 2020³â¿¡¼­ 2050³â »çÀÌ¿¡ 3¹è·Î Áõ°¡ÇÏ¿© 4¾ï 2,600¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© 2024-2031³âÀÇ ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇÑ ¼¼°è ¸Á¸·ÀüÀ§µµ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¸Á¸·Àüµµ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®À» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ¸Á¸·Àüµµ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¸Á¸·Àüµµ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÃÖ±Ù µ¿Çâ
  • Á¦Ç°ÀÇ ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • ÇÕº´, Àμö ¹× Çù¾÷

Á¦4Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå, À¯Çüº°, 2019-2031³â

  • Àü½Ã¾ß ¸Á¸·Àüµµ °Ë»ç(ffERG)
  • ´ÙÃÊÁ¡ ¸Á¸·Àüµµ °Ë»ç(mfERG)
  • ÆÐÅÏ ¸Á¸·Àüµµ °Ë»ç(PERG)
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå, Á¦Ç°º°, 2019-2031³â

  • ÇÚµåÇïµå
  • Å×À̺íÅé

Á¦7Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå, ¿ëµµº°, 2019-2031³â

  • ÀÓ»ó Áø´Ü
  • ¿¬±¸

Á¦8Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå, Áúȯ ÀûÀÀº°, 2019-2031³â

  • ´ç´¢º´¼º ¸Á¸·Áõ
  • ¸Á¸·»ö¼Òº¯¼ºÁõ
  • CRD(Cone-rod Dystrophy)
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°,2019-2031³â

  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð
  • Çмú¿¬±¸±â°ü
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ ¸Á¸·Àüµµ ½ÃÀå, Áö¿ªº°, 2019-2031³â

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • ASEAN
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Cadwell Industries, Inc.
    • Diagnosys LLC.
    • LKC Technologies, Inc.
    • Diopsys, Inc.
    • Konan Medical USA, Inc.
    • Electro-Diagnostic Imaging, Inc.
    • IT
    • Metrovision
    • Roland-consult
    • Neurosoft
    • Ocular Instruments
    • Haag-Streit Group
    • Opto-Medic Co Pte Ltd
    • Stereo Optical
    • M&S Technologies

Á¦12Àå ¼½¼Ç

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
KSA 24.04.24

Global electroretinogram market is valued at US$ 48.7 Mn in 2024 and is expected to reach US$ 90.1 Mn by 2031, growing at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 48.7 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 9.20% 2030/2031 Value Projection: US$ 90.1 Mn
Figure 1. Global Electroretinogram Market Share (%), By Region, 2024
Global Electroretinogram Market - IMG1

Electroretinography is a diagnostic medical test that is used to evaluate the health and function of the retina. It provides objective measurements of the retina's electrical activity by recording how it responds to light stimulus. The test involves placing electrodes on the surface of the eye and the scalp of the patient. A light source is then used to illuminate the retina while recording any electrical responses. The electroretinogram or electroretinogram (ERG) measures the mass electric response of the retina and can help detect retinal abnormalities that are associated with diseases like retinitis pigmentosa. Rising prevalence of retinal disorders worldwide is anticipated to drive increased reliance on ERG for improved diagnosis and management of ocular conditions.

Market Dynamics:

Global electroretinogram market is driven by the growing geriatric population prone to age-related retinal diseases, rising incidence of diabetic retinopathy, growing awareness about eye care, and technological advancements incorporating and multifocal electroretinography. However, the market growth can be restrained by the high cost of electroretinogram devices and non-availability of skilled professionals in many developing regions. Emerging economies offer lucrative opportunities for market players as they witness rapid economic development and healthcare infrastructure expansion. Manufacturers investing in research and development (R&D) of portable devices for point-of-care (POC) testing can also open up opportunities.

A primary driver is the increasing geriatric population, which is more susceptible to age-related retinal diseases such as macular degeneration and glaucoma. As the number of elderly individuals rises globally, the demand for ERG for the diagnosis and monitoring of these conditions also increases. Another significant factor is the rising incidence of diabetic retinopathy, a complication of diabetes that affects the eyes. Growing prevalence of diabetes worldwide has led to an increase in demand for early detection and treatment of eye-related complications, thereby propelling the use of ERG devices. Heightened awareness about eye care and the importance of regular eye examinations has further stimulated the market. Public health initiatives and educational campaigns about eye health have encouraged more people to seek comprehensive eye examinations, which often include ERG testing. Technological advancements, such as the incorporation of multifocal electroretinography, have improved the accuracy and efficiency of ERG devices. These innovations have expanded the applications of ERG in diagnosing and treating a variety of retinal conditions, thus making it a valuable tool for ophthalmologists.

For instance, in October 2022, according to data provided by the World Health Organization (WHO), in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The share of the population aged 60 years and over will increase from 1 million in 2020 to 1.4 million. By 2050, the world's population of people aged 60 years and olders will double (2.1 million). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Key features of the study:

  • This report provides in-depth analysis of the global electroretinogram market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global electroretinogram market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Cadwell Industries Inc, Diagnosys LLC, LKC Technologies, Inc., Diopsys, Inc., Konan Medical USA, Inc., and Electro-Diagnostic Imaging, Inc. CSOITALIA.IT, Metrovision, Roland-consult, Neurosoft, Ocular Instruments, Haag-Streit Group, Opto-Medic Co Pte Ltd, Stereo Optical, and M&S Technologies.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global electroretinogram market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electroretinogram market.

Detailed Segmentation:

  • Global Electroretinogram Market, By Type:
    • Full-field Electroretinography (ffERG)
    • Multi-focal Electroretinography (mfERG)
    • Pattern Electroretinography (PERG)
    • Others
  • Global Electroretinogram Market, By Product:
    • Handheld
    • Table top
  • Global Electroretinogram Market, By Application:
    • Clinical Diagnostic
    • Research
  • Global Electroretinogram Market, By Disease Indication:
    • Diabetic Retinopathy
    • Retinitis pigmentosa
    • Cone-rod Dystrophy
    • Others
  • Global Electroretinogram Market, By End User:
    • Hospitals
    • Ophthalmic Clinics
    • Academic &Research Institutes
    • Others
  • Global Electroretinogram Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in Global Electroretinogram Market:
    • Cadwell Industries, Inc.
    • Diagnosys LLC.
    • LKC Technologies, Inc.
    • Diopsys, Inc.
    • Konan Medical USA, Inc.
    • Electro-Diagnostic Imaging, Inc.
    • IT
    • Metrovision
    • Roland-consult
    • Neurosoft
    • Ocular Instruments
    • Haag-Streit Group
    • Opto-Medic Co Pte Ltd
    • Stereo Optical
    • M&S Technologies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Electroretinogram Market, By Type
    • Electroretinogram Market, By Product
    • Electroretinogram Market, By Application
    • Electroretinogram Market, By Disease Indication
    • Electroretinogram Market, By End User
    • Electroretinogram Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunity
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions,, and Collaborations

4. Global Electroretinogram Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Electroretinogram Market, By Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Full-field Electroretinography (ffERG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Multi-focal Electroretinography (mfERG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Pattern Electroretinography (PERG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Electroretinogram Market, By Product, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Handheld
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Table top
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Electroretinogram Market, By Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Clinical Diagnostic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Electroretinogram Market, By Disease Indication, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Diabetic Retinopathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Retinitis pigmentosa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Cone-rod Dystrophy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

9. Global Electroretinogram Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Ophthalmic Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Academic &Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Other
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

10. Global Electroretinogram Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

11. Competitive Landscape

  • Company Profile
    • Cadwell Industries, Inc.
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Diagnosys LLC.
    • LKC Technologies, Inc.
    • Diopsys, Inc.
    • Konan Medical USA, Inc.
    • Electro-Diagnostic Imaging, Inc.
    • IT
    • Metrovision
    • Roland-consult
    • Neurosoft
    • Ocular Instruments
    • Haag-Streit Group
    • Opto-Medic Co Pte Ltd
    • Stereo Optical
    • M&S Technologies
  • Analyst Views

12. Section

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦